These results are thus consistent with studies from Peng et al., who described that Bregs were decreased in patients with active GvHD (13), and suggest that increased levels of these immunoregulatory populations might play a role in the anti-GvHD effects of MSCs, and more significantly of CXCR4-IL10-MSCs. The gene discussed is IL10; the disease is graft versus host disease.